| abstract |
The selected bis-amino-hydroxyethylaminosulfonamide compounds of formula I are effective retroviral protease inhibitors and in particular HIV protease inhibitors. The present invention relates to retroviral protease inhibitors, and more particularly to selected novel compounds, compositions and methods for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV), prophylactically preventing retroviral infection or retroviral spread, for the treatment of retroviral infection. |